{"id":22063,"date":"2025-02-26T14:18:15","date_gmt":"2025-02-26T19:18:15","guid":{"rendered":"https:\/\/arsacs.com\/?p=22063"},"modified":"2026-03-16T18:17:17","modified_gmt":"2026-03-16T22:17:17","slug":"supporting-research-a-priority-for-the-foundation","status":"publish","type":"post","link":"https:\/\/2026.arsacs.com\/fr\/supporting-research-a-priority-for-the-foundation\/","title":{"rendered":"Supporting Research: A Priority for the Foundation"},"content":{"rendered":"<p>Discover the journey of Betsy Trainor, board member of the Ataxia Charlevoix-Saguenay Foundation, and her commitment to research. Thanks to the Foundation\u2019s funding, Dr. Schmahmann is studying an FDA-approved drug to assess its potential for ARSACS. <a href=\"https:\/\/giving.massgeneral.org\/stories\/finding-new-hope-in-a-rare-disease-fight\">Read the article<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Discover the journey of Betsy Trainor, board member of the Ataxia Charlevoix-Saguenay Foundation, and her commitment to research. Thanks to the Foundation\u2019s funding, Dr. Schmahmann is studying an FDA-approved drug to assess its potential for ARSACS. Read the article<\/p>","protected":false},"author":3,"featured_media":21693,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-22063","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/22063","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/comments?post=22063"}],"version-history":[{"count":2,"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/22063\/revisions"}],"predecessor-version":[{"id":25057,"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/22063\/revisions\/25057"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/media\/21693"}],"wp:attachment":[{"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/media?parent=22063"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/categories?post=22063"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/tags?post=22063"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}